Nomenclature of blood clotting factors; acceptance by the International Committee on nomenclature of four factors, their characteristics and international number.
作者信息
WRIGHT I S
出版信息
Can Med Assoc J. 1958 Apr 15;80(8):659-61.
Abstract
摘要
相似文献
1
2
NOMENCLATURE of blood clotting factors; four factors, their characterization and international number.血液凝血因子的命名；四种因子、其特性及国际编号
J Am Med Assoc. 1959 May 16;170(3):325-8.
3
4
5
[Nomenclature of blood coagulation factors. Recognition, characterization and international numbering of 4 blood coagulation factors (V, VII, VIII, IX) by the International Committee for the Nomenclature of Blood Coagulation Factors].[血液凝固因子的命名法。国际血液凝固因子命名委员会对4种血液凝固因子（V、VII、VIII、IX）的识别、特征描述及国际编号]
Dtsch Med Wochenschr. 1959 Sep 25;84:1790-2. doi: 10.1055/s-0028-1114527.
6
7
Nomenclature for congenital and paediatric cardiac disease: historical perspectives and The International Pediatric and Congenital Cardiac Code.先天性和儿科心脏病的命名法：历史视角与《国际儿科和先天性心脏病编码》
Cardiol Young. 2008 Dec;18 Suppl 2:70-80. doi: 10.1017/S1047951108002795.
8
NOMENCLATURE of blood-clotting factors.血液凝固因子的命名
Br Med J. 1959 May 16;1(5132):1288-9.
9
Analysis of outcomes for congenital cardiac disease: can we do better?先天性心脏病治疗结果分析：我们能否做得更好？
Cardiol Young. 2007 Sep;17 Suppl 2:145-58. doi: 10.1017/S1047951107001278.
10
Nomenclature and databases for the surgical treatment of congenital cardiac disease--an updated primer and an analysis of opportunities for improvement.先天性心脏病外科治疗的命名法与数据库——最新入门指南及改进机会分析
Cardiol Young. 2008 Dec;18 Suppl 2:38-62. doi: 10.1017/S1047951108003028.
引用本文的文献
1
The legacy of haemophilia: Memories and reflections from three survivors.血友病的遗绪：三位幸存者的回忆与反思。
Haemophilia. 2022 Sep;28(5):872-884. doi: 10.1111/hae.14587. Epub 2022 May 19.
2
The Clinical Genetics of Hemophilia B (Factor IX Deficiency).B型血友病（因子IX缺乏症）的临床遗传学
Appl Clin Genet. 2021 Nov 23;14:445-454. doi: 10.2147/TACG.S288256. eCollection 2021.
3
Factor Xa: Thrombokinase from Paul Morawitz to J Haskell Milstone.Xa 因子：凝血酶原激酶，从保罗·莫拉维茨到哈斯克尔·米尔斯坦。
J Thromb Thrombolysis. 2021 Aug;52(2):364-370. doi: 10.1007/s11239-021-02387-6. Epub 2021 Jan 23.
本文引用的文献
1
THE CLOTTING BEHAVIOR OF HUMAN "PLATELET-FREE" PLASMA: EVIDENCE FOR THE EXISTENCE OF A "PLASMA THROMBOPLASTIN".人“无血小板”血浆的凝血行为：“血浆凝血活酶”存在的证据
J Clin Invest. 1949 Mar;28(2):340-52. doi: 10.1172/JCI102077.
2
The prothrombin conversion accelerator of serum (SPCA): its partial purification and its properties compared with serum AC-globulin.血清凝血酶原转化加速因子（SPCA）：其部分纯化及其与血清AC球蛋白相比的特性。
J Clin Invest. 1950 Jul;29(7):881-95. doi: 10.1172/JCI102322.
3
Studies on the role of calcium in the coagulation of blood.钙在血液凝固中作用的研究。
Acta Med Scand. 1950;136(4):250-66. doi: 10.1111/j.0954-6820.1950.tb09637.x.
4
Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia.血浆凝血活酶成分（PTC）缺乏症；一种类似血友病的新疾病。
Proc Soc Exp Biol Med. 1952 Apr;79(4):692-4. doi: 10.3181/00379727-79-19488.
5
Application of paper electrophoresis to separation of blood-clotting factors.纸电泳在血液凝固因子分离中的应用。
J Appl Physiol. 1954 May;6(11):696-700. doi: 10.1152/jappl.1954.6.11.696.
6
Differentiation of hemophilia into two groups; a study of thirty-three cases.血友病分为两组的研究；33例病例分析。
N Engl J Med. 1953 Oct 1;249(14):547-53. doi: 10.1056/NEJM195310012491401.
7
Seminars on blood coagulation; mechanism of blood coagulation in normal and pathologic conditions.血液凝固研讨会；正常及病理状态下的血液凝固机制。
Am J Med. 1953 Jan;14(1):64-86. doi: 10.1016/0002-9343(53)90359-3.
Zotero 插件